Biomarker-based staging of Alzheimer disease: rationale and clinical applications

Joseph Therriault(Douglas Mental Health University Institute), Pedro Rosa‐Neto(Center for Diagnosis and Research on Alzheimer's Disease), Clifford R. Jack(Mayo Clinic), Tharick A. Pascoal(Montreal Neurological Institute and Hospital), Nicholas J. Ashton(King's College London), Renaud La Joie(University of California, San Francisco), Randall J. Bateman(Washington University in St. Louis), Kaj Blennow(Sahlgrenska University Hospital), Philip Scheltens(Amsterdam University Medical Centers), Liana G. Apostolova(University of California, Los Angeles), Reisa A. Sperling(Harvard University), Andréa Lessa Benedet(University of Pittsburgh), Oskar Hansson(Eli Lilly (United States)), Gil D. Rabinovici(University of California, San Francisco), Thomas K. Karikari(University of Pittsburgh), Gemma Salvadó(Lund University), Inge M.W. Verberk(Amsterdam Neuroscience), Charlotte E. Teunissen(Amsterdam Neuroscience), Suzanne E. Schindler(Washington University in St. Louis), Henrik Zetterberg(University of Wisconsin–Madison), Jacob W. Vogel(Malmö University), Melissa E. Murray(Jacksonville College), Serge Gauthier(Texas Instruments (France))
Nature Reviews Neurology
March 1, 2024
Cited by 171


Related Papers